| revised_iss_multiple_myeloma | R Documentation |
Calculates the Revised International Staging System (R-ISS) for multiple myeloma. This system combines the original ISS (serum beta-2 microglobulin and albumin) with chromosomal abnormalities (CA) detected by iFISH and serum lactate dehydrogenase (LDH) levels to improve prognostic stratification.
revised_iss_multiple_myeloma(beta2_microglobulin, albumin, ldh_elevated,
high_risk_chromosomal_abnormalities)
beta2_microglobulin |
Numeric. Serum Beta-2 Microglobulin level in mg/L. |
albumin |
Numeric. Serum Albumin level in g/dL. |
ldh_elevated |
Numeric (0 or 1). Is serum LDH greater than the upper limit of normal? (1 = Yes). |
high_risk_chromosomal_abnormalities |
Numeric (0 or 1). Presence of high-risk chromosomal abnormalities by iFISH (del(17p), t(4;14), or t(14;16)). (1 = Yes). |
Staging Criteria:
R-ISS I: ISS Stage I (B2M < 3.5 and Alb >= 3.5) AND No High Risk CA AND Normal LDH.
R-ISS III: ISS Stage III (B2M >= 5.5) AND (High Risk CA OR High LDH).
R-ISS II: Not R-ISS I or III.
A list containing:
R_ISS_Stage |
The calculated R-ISS Stage (I, II, or III). |
ISS_Stage_Calculated |
The underlying standard ISS stage. |
Median_Overall_Survival |
Estimated median overall survival. |
Five_Year_Survival |
Estimated 5-year overall survival rate. |
Palumbo A, Avet-Loiseau H, Oliva S, et al. Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group. J Clin Oncol. 2015;33(26):2863-2869. doi:10.1200/JCO.2015.61.2267
# Example 1: R-ISS Stage I
# B2M 2.0, Alb 4.0 (ISS I), Normal LDH, No High Risk CA
revised_iss_multiple_myeloma(2.0, 4.0, 0, 0)
# Example 2: R-ISS Stage III
# B2M 6.0 (ISS III), High LDH
revised_iss_multiple_myeloma(6.0, 3.0, 1, 0)
# Example 3: R-ISS Stage II
# B2M 2.0, Alb 4.0 (ISS I), but High LDH (Disqualifies R-ISS I)
revised_iss_multiple_myeloma(2.0, 4.0, 1, 0)
Add the following code to your website.
For more information on customizing the embed code, read Embedding Snippets.